CD4 and inflammatory breast carcinoma: Of note, the percentage of CD4+ T cells that were FoxP3+ and CD25high (regulatory T cells; Treg) did not differ between our IBC patient and healthy control cohorts (data not shown), in contrast to the Mego et al. report of decreased numbers of Tregs in metastatic IBC patients compared to non-metastatic IBC patients and healthy controls [28].